Nyxoah (NASDAQ:NYXH - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.46) by ($0.03), Zacks reports. Nyxoah had a negative net margin of 1,043.93% and a negative return on equity of 51.68%.
Nyxoah Trading Up 7.7 %
Shares of NYXH stock opened at $10.48 on Thursday. The company has a market cap of $356.78 million, a P/E ratio of -5.66 and a beta of 1.42. Nyxoah has a fifty-two week low of $6.76 and a fifty-two week high of $20.00. The stock has a 50 day simple moving average of $10.24 and a two-hundred day simple moving average of $9.16. The company has a debt-to-equity ratio of 0.21, a quick ratio of 4.95 and a current ratio of 5.28.
Analyst Ratings Changes
Separately, HC Wainwright reaffirmed a "buy" rating and set a $17.00 price objective on shares of Nyxoah in a research report on Friday, December 13th.
Read Our Latest Stock Report on Nyxoah
Nyxoah Company Profile
(
Get Free Report)
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nyxoah, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nyxoah wasn't on the list.
While Nyxoah currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
